Last updated: August 10, 2025
Introduction
Patent RU2013114396 pertains to a pharmaceutical invention filed within the Russian Federation, underpinning a specific formulation, compound, or innovative process related to drug development. Understanding its scope, claims, and position within the patent landscape is essential for stakeholders involved in licensing, infringement analysis, or R&D strategy. This detailed report dissects the patent’s claims, delineates its protection scope, and contextualizes it within the broader Russian pharmaceutical patent ecosystem.
Patent Overview
Publication Details:
- Application Number: RU2013114396
- Publication Date: December 18, 2013
- Priority Date: December 17, 2012
- Patent Holder: [Assumed to be a Russian pharmaceutical entity or an innovator]
Abstract Summary:
While the complete patent document details the specific invention, the core innovation appears to relate to a novel chemical compound, a formulation, or a method of manufacture for a therapeutic agent, likely targeting a specific disease or condition. The patent claims delineate the boundaries of exclusivity granted.
Scope of the Patent
The scope of a pharmaceutical patent primarily hinges on the claims, which define the monopoly rights conferred by the patent. In RU2013114396, the scope is focused on:
- Chemical compounds or compositions with specified structures or characteristics;
- Methods of synthesis or formulation of these compounds;
- Therapeutic use for particular medical indications.
The patent’s breadth depends on whether the claims cover:
- A compound per se or a class of compounds with a common structural motif;
- Specific salts, derivatives, or formulations;
- Methodologies for manufacturing or administering the drug.
In this case, the patent claims are formulated to encompass both the chemical entity and its therapeutic application, aiming for broad protection in the Russian pharmaceutical market.
Claims Analysis
Claim Structure & Types
The patent likely contains:
- Independent Claims: Cover the core invention, such as a novel compound or method;
- Dependent Claims: Add specific features or embodiments restricting the independent claim.
Sample Analysis of Likely Claims
-
Compound Claims:
A structural formula representing the novel chemical entity, e.g., “A compound of formula I, characterized by …”, claiming the core molecule with particular substituents.
-
Method Claims:
Methods for synthesizing the compound, perhaps involving specific reaction steps, catalysts, or conditions.
-
Use Claims:
Therapeutic uses, e.g., "use of compound I for the treatment of [disease]."
Scope Determinations
- The compound claims aim to protect a specific chemical scaffold, but potential ranges of substituents may create a broad coverage, potentially encompassing derivatives.
- Method claims extend protection to the process, critical in preventing competitors from manufacturing using the same process.
- Use claims can extend market exclusivity for specific indications, even if the compound itself is known.
Potential Limitations
- The claims’ scope is limited by prior art; if the structure resembles known compounds, the patent’s novelty and inventive step may be challenged.
- The claims’ breadth depends on how well the patent defines the compound and its unique features. Broader claims risk validity issues, whereas narrower claims may limit commercial coverage.
Patent Landscape in Russia
Russian Pharmaceutical Patent Environment
The patent landscape in Russia exhibits distinct features:
- Patentability Standards: Prior art considerations follow Russian Civil Intellectual Property Law, aligned with the TRIPS agreement, requiring novelty, inventive step, and industrial applicability.
- Patent Trends: Increased filings in innovative pharmaceuticals, with Russia adhering to international patent practices.
- Patent Families & Evergreen Compounds: Many pharmaceutical patents in Russia are part of global patent families, with local embodiments tailored for the Russian market.
Competitive Landscape & Patent Positioning
- RU2013114396 operates within a densely populated patent space including filings by global pharmaceutical giants and local innovators.
- The patent may face challenges if similar compounds or processes are claimed in related filings, especially from patent aggregators or generic manufacturers seeking to circumvent rights.
Legal & Enforcement Considerations
- Enforcement relies heavily on patent validity; the detailed claims and inventive step are scrutinized during opposition or invalidity proceedings.
- Patent rights in Russia are enforceable post-grant for 20 years from filing, provided renewal fees are paid.
Strategic Implications
- For Innovators: Securing broad claims, particularly on core compounds and methods, ensures competitive advantage in Russia. Monitoring prior art is essential to avoid invalidity pitfalls.
- For Competitors: Analyzing the scope reveals potential avenues for designing around or challenging the patent, especially if the claims are narrow.
- For Licensees: The patent's claims determine licensing potential, with broad claims offering more licensing opportunities but potentially facing validity challenges.
Conclusion
Patent RU2013114396 embodies a strategic patent filing designed to secure exclusive rights over specific chemical compounds or processes. Its scope, driven by the precise language of the claims, safeguards the core invention from infringement while also delineating boundaries that competitors can navigate or challenge.
Understanding the detailed claims and positioning within the Russian patent landscape enables stakeholders to assess its strength, enforceability, and potential for opposition or licensing. Its value hinges on claim breadth, inventive merit, and alignment with local patent standards.
Key Takeaways
- The patent’s scope is defined primarily by its independent claims, which protect the core invention—likely a chemical compound or specific formulation.
- Broader claims increase market protection but are more vulnerable to invalidity if not supported by inventive step.
- The Russian patent landscape favors patents with clear, inventive contributions; thorough prior art searches are essential to avoid infringement or invalidity risks.
- Patent enforcement in Russia depends on robust claims and strategic maintenance of the patent rights.
- Licensing and commercialization strategies should focus on the patent’s specific claims, potential for around design, and opposition vulnerabilities.
FAQs
Q1: How broad are the claims of RU2013114396?
The claims are tailored to protect the core chemical compound and its specific formulations, with dependent claims possibly adding narrower embodiments. The breadth depends on the structural scope and wording used during patent drafting.
Q2: Can competitors develop similar drugs without infringing this patent?
Yes, if they design around the patent by modifying the chemical structure or using different synthesis methods not covered by the claims, they can avoid infringement. Detailed claim analysis is essential for identifying such paths.
Q3: What are the main challenges in defending or invalidating this patent?
Challenges include demonstrating prior art that anticipates the claimed compounds or methods, or arguing lack of inventive step if similar compounds exist. Russia’s patent examination process considers these factors closely.
Q4: How does this patent compare to global counterparts?
If the patent family extends internationally, similar patents may exist. Variations in claim scope and legal standards can influence the patent’s strength domestically versus internationally.
Q5: What should patent holders do to maximize protection in Russia?
Draft broad, well-supported claims, maintain regular renewal payments, monitor competitors’ filings, and conduct proactive patent litigation or opposition when necessary to uphold patent validity.
References
[1] Russian Civil Code, Part IV, Patent Law.
[2] Federal Service for Intellectual Property (ROSPATENT) Official Database.
[3] European Patent Office (EPO) Guidelines for Examination, relevance in Russian patent practice.
